Literature DB >> 8823299

Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

B Gulwani-Akolkar1, P N Akolkar, A Minassian, R Pergolizzi, M McKinley, G Mullin, S Fisher, J Silver.   

Abstract

To identify disease-specific T cell changes that occur in Crohn's disease (CD), the T cell receptor BV repertoires of lamina propria lymphocytes (LPL) isolated from both the inflamed and "disease-inactive" colons of seven CD patients were compared by the quantitative PCR and DNA sequence analysis. It was observed that the BV repertoires of LPL isolated from the disease-active and disease-inactive parts of the colon from the same individual were very different. Furthermore, nearly all of the differences occurred in CD4+ LPL, with very few differences in the CD8+ population of LPL. Although the pattern of BV segments that was increased in disease-active tissue relative to disease-inactive tissue was different for all seven CD patients, there were several BV segments that increased uniformly in the disease-active tissue of all seven individuals. CDR3 length analysis and DNA sequencing of these BV segments revealed that in six of the seven CD patients there was a striking degree of oligoclonality that was absent from disease-inactive tissue of the same individual. These observations suggest that at least some of the inflammation in CD is the result of responses by CD4+ T cells to specific antigens. The isolation of such inflammation-specific CD4+ T cells may make it possible to identify the antigens that are responsible for the inflammatory process in CD and provide a better understanding of its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823299      PMCID: PMC507560          DOI: 10.1172/JCI118921

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

2.  Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.

Authors:  A Raedler; S Fraenkel; G Klose; H G Thiele
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

3.  Lymphocyte activation in vivo in the intestinal mucosa of patients with Crohn's disease.

Authors:  Y T Konttinen; V Bergroth; D Nordström; M Segerberg-Konttinen; K Seppälä; M Salaspuro
Journal:  J Clin Lab Immunol       Date:  1987-02

Review 4.  Crohn's disease. New concepts of pathogenesis and current approaches to treatment.

Authors:  S P James; W Strober; T C Quinn; S H Danovitch
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

5.  Immunoregulatory function of lamina propria T cells in Crohn's disease.

Authors:  S P James; C Fiocchi; A S Graeff; W Strober
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

Review 6.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

7.  Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease.

Authors:  A Raedler; S Fraenkel; G Klose; K Seyfarth; H G Thiele
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

Review 8.  Recent developments in nonspecific inflammatory bowel disease (second of two parts).

Authors:  J B Kirsner; R G Shorter
Journal:  N Engl J Med       Date:  1982-04-08       Impact factor: 91.245

9.  Isolation and functional characterization of human intestinal mucosal lymphoid cells.

Authors:  D M Bull; M A Bookman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Crohn's disease is accompanied by changes in the CD4+, but not CD8+, T cell receptor BV repertoire of lamina propria lymphocytes.

Authors:  B Gulwani-Akolkar; P N Akolkar; M McKinley; S E Fisher; J Silver
Journal:  Clin Immunol Immunopathol       Date:  1995-10
View more
  15 in total

1.  Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells.

Authors:  M Camus; S Esses; B Pariente; L Le Bourhis; C Douay; V Chardiny; I Mocan; K Benlagha; E Clave; A Toubert; L Mayer; M Allez
Journal:  Mucosal Immunol       Date:  2013-08-14       Impact factor: 7.313

Review 2.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD).

Authors:  S Bregenholt; M H Claesson
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.

Authors:  P Parronchi; P Romagnani; F Annunziato; S Sampognaro; A Becchio; L Giannarini; E Maggi; C Pupilli; F Tonelli; S Romagnani
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

5.  Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.

Authors:  Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Bárbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

6.  Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Seiichi Kitagawa; Kenji Watanabe; Yasuhiro Fujiwara; Kazuhide Higuchi; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 7.  Oligoclonal T cells in human cancer.

Authors:  E Halapi
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

Review 8.  Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases.

Authors:  Jonathan J Hansen
Journal:  Curr Allergy Asthma Rep       Date:  2015-10       Impact factor: 4.806

9.  Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Yoshio Jinno; Yoshinori Sawa; Junichi Hara; Shiro Nakamura; Takayuki Matsumoto; Tetsuo Arakawa; Atsuo Kitano; Seiichi Kitagawa; Tetsuo Kuroki
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

10.  An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Authors:  C Schaufelberger; R Andersson; E Nordborg; G K Hansson; C Nordborg; J Wahlström
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.